Cantor Fitzgerald Reiterates Overweight Rating for Enovix (NASDAQ:ENVX)

Enovix (NASDAQ:ENVX)‘s stock had its “overweight” rating reiterated by analysts at Cantor Fitzgerald in a report released on Thursday,Benzinga reports. They currently have a $25.00 price objective on the stock. Cantor Fitzgerald’s target price indicates a potential upside of 428.54% from the stock’s previous close.

Several other equities analysts have also weighed in on the stock. JPMorgan Chase & Co. lowered shares of Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. Benchmark decreased their price objective on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. TD Cowen reduced their target price on Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, July 24th. Finally, Oppenheimer decreased their price target on Enovix from $24.00 to $21.00 and set an “outperform” rating on the stock in a research note on Thursday, May 14th. Six analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $12.50.

Enovix Stock Down 2.1%

Shares of NASDAQ:ENVX opened at $4.73 on Thursday. Enovix has a 52-week low of $3.67 and a 52-week high of $14.21. The stock has a market cap of $1.03 billion, a P/E ratio of -5.70 and a beta of 2.32. The business has a fifty day moving average of $5.47 and a two-hundred day moving average of $5.90. The company has a quick ratio of 10.65, a current ratio of 10.97 and a debt-to-equity ratio of 2.14.

Enovix (NASDAQ:ENVX) last announced its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.02. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The firm had revenue of $9.02 million for the quarter, compared to analysts’ expectations of $8.43 billion. During the same quarter in the previous year, the company posted ($0.13) EPS. The company’s revenue was up 20.8% compared to the same quarter last year. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. On average, research analysts expect that Enovix will post -0.79 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ENVX. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Enovix during the 2nd quarter worth approximately $8,689,000. Cauble & Harre Wealth Management Inc. purchased a new position in Enovix in the 2nd quarter valued at approximately $796,000. Allworth Financial LP acquired a new position in shares of Enovix in the second quarter worth $71,000. Wealthfront Advisers LLC acquired a new position in shares of Enovix in the second quarter worth $94,000. Finally, BlackRock Inc. purchased a new stake in shares of Enovix during the second quarter worth $100,054,000. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix News Summary

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Enovix reported second-quarter adjusted EPS of a $0.13 loss, beating analysts’ expected $0.15 loss. Revenue reached $9.02 million, up 20.8% year over year and ahead of consensus estimates. Enovix Reports Second Quarter 2026 Results
• Positive Sentiment: Management continued to highlight potential demand for Enovix’s silicon-anode batteries across smartphones, wearables and defense applications. These markets could support longer-term growth if the company successfully scales production and converts customer interest into commercial orders. ENVX stock falls overnight despite Q2 beat
• Neutral Sentiment: For the third quarter, Enovix guided to an adjusted EPS loss of $0.17 to $0.13, broadly near the $0.15 consensus estimate. The company’s revenue outlook of $9 million to $10 million implies continued growth but remains below the approximately $10.3 million analyst expectation. Enovix Q2 2026 Earnings Call Transcript
• Negative Sentiment: Enovix remains deeply unprofitable, with a quarterly net margin of roughly negative 500% and a negative return on equity. The company also expects another quarterly loss, reinforcing concerns about the timing of profitability and the execution risks involved in scaling its battery technology. Enovix Reports Q2 Loss, Tops Revenue Estimates
• Negative Sentiment: The revenue-guidance shortfall appears to have outweighed the earnings beat, contributing to weaker investor sentiment. ENVX is trading below both its 50-day and 200-day moving averages, indicating continued technical pressure.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.